ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698931; 2) Community: the network communities that were significantly associated with the response to NSC 698931; 3) Molecule: the relationships between components within communities and NSC 698931; 4) MDR: the compounds that were significantly associated with the NSC 698931.

NSC Compound Enrichment Correlation
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.0403978426119741 0.31763817
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0403978426119741 0.49947745
NSC 89671 Ascotoxin 0.0403978426119741 0.0062503911
NSC 8985 WLN: 1R D-I-R D1 &E &6/14 0.0403978426119741 0.15509221
NSC 98904 Thiazolo[3,2-f]phenanthridinium, 3-phenyl- perchlorate 0.0403978426119741 0.20070039
NSC 752384 Null 0.0404100698195774 -0.10723364
NSC 670678 Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester 0.0404100698195776 -0.20273625
NSC 100046 Elephantopin 0.0421163101172308 0.19502644
NSC 113951 6-Bromotoyocamycin 0.0421163101172308 0.49067258
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0421163101172308 0.46186456
Total:202  Current:189    [First] [Prev] [Next] [Last]